dpp-4 inhibitors vs. glp-1 agonist GLP 1 Receptor Agonists and DPP 4 Mechanism of Action fig2.gif
Description
35 As mentioned, in the absence of T2DM, nearly all glucose filtered through the glomeruli is reabsorbed via SGLTs
CBF, Cerebral Blood Flow
It was developed by Sanofi Aventis under a license from Zealand Pharma
sulfonylureas) may be indicated to avoid hypoglycaemia
